Cargando...
Warfarin Dosing in Patients With Impaired Kidney Function
BACKGROUND: Warfarin, a drug primarily metabolized by the cytochrome P450 system, is initiated at similar doses and managed similarly in patients with kidney impairment as in the general medical population. Unfortunately, few data exist to guide dose adjustment in patients with reduced kidney functi...
Gardado en:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2963672/ https://ncbi.nlm.nih.gov/pubmed/20709439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2010.05.023 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|